Nonstandard abbreviations: AC, adenylyl cyclase; AC6, adenylyl cyclase type 6; AC6mut, adenylyl cyclase type 6 mutant; ATP, adenosine 5'-triphosphate; cAMP, 3',5'-cyclic adenosine monophosphate; PHLPP2, pleckstrin homology domain leucine-rich repeat protein phosphatase 2; PE, phenylephrine; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; 
INTRODUCTION
Adenylyl cyclase (AC) is the effector molecule for β-adrenergic receptor (βAR) and other Gprotein coupled receptors in cardiac myocytes and other cells. AC regulates the conversion of adenosine 5'-triphosphate (ATP) to 3',5'-cyclic adenosine monophosphate (cAMP) and initiates a variety of intracellular signaling events that influence heart function (Post et al., 1995; Hanoune et al., 1997; Tesmer and Sprang, 1998; Hurle, 1999) . Nine isoforms of mammalian AC have been identified so far, all possessing a short intracellular amino terminus, and two large cytoplasmic domains (C1 and C2) separated by two transmembrane domains (M1 and M2) each containing 6 transmembrane spans (Sunahara et al., 1996; Hanoune et al., 1997; Tesmer and Sprang, 1998; Smit and Iyengar, 1998; Hurle, 1999) . The C1 and C2 domains form the catalytic core of AC and have activity with or without the two transmembrane domains (Tang and Gilman, 1995; Yan et al., 1996; Whisnant et al., 1996) . The catalytic activity of AC is regulated by many factors: GTP binding proteins, ATP, Mg 2+ , glycosylation and phosphorylation (Iwami et al., 1995; Dessauer and Gilman, 1996; Tesmer et al., 1997; Dessauer et al., 1997 and Wu et al., 2001; Lin et al., 2002; Chen-Goodspeed et al., 2005) . However, intracellular AC appears to interact with intracellular proteins and influence signaling independently of its catalytic activity.
For example, interaction of AC type 6 (AC6) with a PH-domain leucine-rich phosphatase protein 2 (PHLPP2) inhibits PHLPP2 activity, which leads to increased Akt phosphorylation and activity (Brognard et al., 2007; Gao et al., 2009 ).
β-adrenergic receptor (βAR) activation or pharmacological reagents that increase cAMP have deleterious effects on the heart (Gaudin et al., 1995; Communal et al., 1998; Engelhard et al., 1999 and Bisognano et al., 2000; Singh et al., 2001) . However, increased expression of AC6, which increases agonist-stimulated cAMP, has beneficial effects (Gao et al., 1999 and MOL #67298 This article has not been copyedited and formatted. The final version may differ from this version. Roth et al., 1999 and Takahashi et al., 2006; Lai et al., 2000 Lai et al., , 2004 Lai et al., , and 2008 , suggesting that AC6 expression has biological effects that may be unrelated to cAMP generation.
Using pharmacological inhibitors, our previous data support this notion . Because of the inherent limitations of studies using pharmacological inhibition, we generated a catalytically inactive AC6 mutant (AC6mut) molecule by substitution of alanine for aspartic acid at position 426 in the C1 domain of the catalytic core. Based on the crystal structure of the C1C2 catalytic core resolved by Gilman's group, this amino acid is required for magnesium binding, but not critical for the overall structure of the catalytic core (Tesmer et al., 1997) . This catalytically inactive mutant of AC6 enabled us to determine whether the beneficial effects of AC6 on intracellular signaling, calcium handling, and cardiac myocyte hypertrophy and apoptosis are cAMP-independent.
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MATERIALS AND METHODS

Adult rat cardiac myocyte culture and gene transfer
Adult rat cardiac myocytes were isolated from 10-week-old Sprague-Dawley rats as described previously (Patel et al., 2006) . Isolated cardiac myocytes were suspended in M199 medium (Invitrogen, Carlsbad, CA) supplemented with 1% bovine serum albumin (HyClone, Logan, UT), 100 IU/ml penicillin, and 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA), and were plated on laminin-coated dishes. The culture medium was changed to fresh medium to remove the damaged myocytes that failed to attach after 2 hr in the plate. At this point, about 70 -80% myocytes were viable and rod-shaped. Gene transfer was performed by infecting cells with E1-deleted adenoviruses encoding murine AC6 (Ad.AC6) or AC6 mutant (Ad.AC6mut) at 2 x 10 7 virus particles per well of a 12-well plate. An adenovirus vector lacking a transgene insert (Ad.Null; Invitrogen, Carlsbad, CA) was used as an additional control.
AC activity
Adult rat cardiac myocytes were seeded in 12-well plates at 15,000 cells/well. After washing and changing media, about 12,000 cells remain in the well. Cells were incubated with Ad.AC6mut or Ad.AC6 for 44 hr and stimulated with isoproterenol (Sigma, 10 µM, 10 min) or forskolin (Sigma, 10 µM, 10 min) or were not stimulated (basal). Cells were lysed in lysis buffer 1B (2.5% dodecyltrimethyammonium bromide, 0.05 M sodium acetate, pH 5.8, and 0.02% bovine serum albumin). The amount of cAMP in the supernatant was measured using the cAMP Biotrak Enzymeimmunoassay System (GE Healthcare, Waukesha, WI) following the instructions from the provider.
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Calcineurin activity
Calcineurin activity was assayed using a "Calcineurin cellular activity assay kit" from Enzo life Sciences. Briefly, cells were lysed in lysis buffer containing protease inhibitors, passed through a 18g needle, and centrifuged at 16,000 x g at 4 o C for 60 min. Supernatant was desalted by gel filtration. After determined protein concentration, same amount of protein (1.1 μg) was used in calcineurin activity assay. The results, amount of phosphate released by calcineurin, were calculated using slope and intercept obtained from standard curve.
Immunoblotting, immunoprecipitation and immunofluorescence staining were performed as described previously .
Cardiac myocyte hypertrophy and apoptosis
To determine how AC6 and AC6mut influence cardiac myocyte response to a hypertrophic stimulus, isolated adult cardiac myocytes were infected with Ad.AC6, Ad.AC6mut or Ad.Null for 24 hr followed by incubation with phenylephrine (PE, Sigma, 20 µM) for 44 hr. In alternative experiments, PE was incubated with cardiac myocytes for 24 hr followed by incubation with Ad.AC6, Ad.AC6mut, or Ad.Null for 24 hr. Cardiac myocyte size was measured from imaged photos using "Metamorph" software, an integrated morphometry analysis (Molecular Devices, Sunnyvale, CA) stipulating a cell length of ≥ 107 µm. Dead cardiac myocytes, defined as small, dense, and rounded cells (Merkus et al., 2005) were counted, confirmed by exclusion of trypan blue (Zaugg M, 2002) , and expressed as a percentage of total cells. Cardiac myocyte apoptosis was determined using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). Total cells (untreated, 700-800; PE treated, 500-600) and apoptotic cells
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Measurements of Cytoplasmic Ca
2+
Cardiac myocytes were isolated from adult rat and plated on laminin-coated 25-mm glass coverslips. Cells were infected with Ad.Null, Ad.AC6, or Ad.AC6mut for 48 hr and stimulated with isoproterenol (10 μM) for 20 hr. Cytoplasmic Ca 2+ was measured as described previously .
Statistical analysis
Data represent mean ± SD; group differences were tested for statistical significance using one-way ANOVA, followed by Bonferroni t-testing. The null hypothesis was rejected when p < 0.05.
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RESULTS
Expression and location of AC6mut
Both transgene AC6 and AC6mut proteins were increased 20-25-fold over endogenous AC6 in uninfected and Ad.Null controls (Fig. 1A) , and showed similar distribution to plasma membrane/caveolae and sarcoplasmic reticulum (Fig. 1B) .
AC6 and AC6mut activity
Neither AC6 nor AC6mut expression altered basal cAMP (AC6: 3±3 fmol/µg; AC6mut: 3±2 fmol/µg; Control: 2±1fmol/µg.) AC6 gene transfer was associated with increased cAMP production when stimulated with isoproterenol (AC6: 623±223 fmol/µg; Con: 22±6 fmol/µg; p<0.001) and forskolin (AC6: 2842 ± 133 fmol/µg; Con: 636 ± 25 fmol/µg; p<0.001) (Fig. 1C) .
However, AC6mut expression was associated with a 59% reduction in cAMP production stimulated by isoproterenol (AC6mut: 9±8 fmol/µg; Con: 22± 6 fmol/µg; p>0.05) and with an 80% reduction in forskolin stimulated cAMP production (AC6mut: 130±5 fmol/µg; Con 636±25 fmol/µg; p<0.001; Fig. 1C ). These data demonstrate that AC6mut expression markedly reduces cAMP generating capacity and may interfere with endogenous AC activity.
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2C).
In uninfected or Ad.Null infected cells, PE increased atrial natriuretic factor (ANF) mRNA expression by 1.5-fold, (p>0.05). Increased AC6 reduced, but not significantly, ANF expression after PE treatment. AC6mut acted similarly to Ad.Null control (Fig. 3A) . PE increased B-type natriuretic peptide (BNP) mRNA by 2-fold (p<0.001). Increased AC6 and AC6mut expression
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CARP expression
Next, we examined the effects of AC6 and AC6mut expression on cardiac ankyrin repeat protein (CARP), a fetal gene activated during cardiac myocyte hypertrophy (Aihara et al., 2000; Maeda et al., 2002 CARP protein expression was also reduced by increased AC6 and AC6mut expression ( Fig. 3C and 3D). Clearly increased AC6 and AC6mut expression reduce PE-induced CARP expression, through unknown mechanisms.
Calcineurin expression and activity
Increased expression of calcineurin A has been described in the setting of cardiac myocyte hypertrophy (De Windt et al., 2000; Bousette et al., 2010) . However, we found that PE neither changed calcineurin A expression no calcineurin activity in all groups ( Fig.3E and 3F ). These data suggest that AC6 and AC6mut induced reduction in cardiac myocyte hypertrophy seems not through suppression of calcineurin signaling pathway.
SR Ca 2+ storage
To determine whether AC6 or AC6mut expression was associated with alterations in SR This article has not been copyedited and formatted. The final version may differ from this version. Fig. 4B ). An apparent difference between AC6 and AC6mut did not reach statistical significance. These data indicate that despite impaired cAMP generation, AC6mut has the ability to increase cardiac myocyte SR Ca 2+ storage.
Expression and phosphorylation of phospholamban
To determine possible mechanisms the increased Ca 2+ handling seen following AC6 and AC6mut gene transfer, we examined the effects of AC6 and AC6mut expression on phospholamban (PLB) and troponin I (TnI) expression and phosphorylation. Gene transfer of AC6 or AC6mut reduced PLB expression by 46% ± 18 (p<0.05) and 41% ± 23 (p<0.05), respectively (Fig. 5A) .
The extent of PLB phosphorylation at the Ser16 or Thr17 sites in adult rat cardiac myocytes is low. Gene transfer of AC6, but not AC6mut, increased basal PLB phosphorylation at Ser16 by 7.3-fold (p<0.001; Fig. 5B ). After isoproterenol stimulation, phospho-Ser16 was increased, but there were no group differences (Fig. 5B ). AC6 and AC6mut gene transfer did not increase basal PLB phosphorylation at the Thr17 site. After isoproterenol stimulation, AC6, but not AC6mut, increased PLB phosphorylation at the Thr17 site 2-fold (Fig. 5C ).
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This article has not been copyedited and formatted. The final version may differ from this version. The striking similarity in the direction and degree of these changes between a catalytically active (AC6) and a catalytically inactive mutant (AC6mut) indicates that such alterations do not require increased cAMP. We conclude that many of the beneficial biological effects of AC6 do not require increases in cAMP.
We previously have shown that increased expression of AC6 in neonatal rat cardiac myocytes alters intracellular signaling events (Gao et al., , and 2010 , but the precise mechanism has remained elusive. In the present study, we confirmed that most of the effects of AC6 expression seen in neonatal rat cardiac myocytes (Gao et al., , 2009 (Gao et al., and 2010 also are present in adult rat cardiac myocytes. More importantly, in the present study, exploiting a catalytically inactive AC6 enabled us to identify the effects of AC6 expression that might be cAMP independent. This strategy was productive and provided novel information.
Cyclic AMP dependent effects
It is important to point out that, as anticipated, not all of AC6's effects were cAMPindependent. For example: 1) After AC6 gene transfer, PE stimulation was associated with increased PLB phosphorylation at the Ser16 and Thr17 sites ( Fig. 3A and 3B) , a cAMP-
This article has not been copyedited and formatted. The final version may differ from this version. AC6mut inhibited forskolin stimulated AC activity (Fig. 1C) . Although forskolin is a direct AC
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This article has not been copyedited and formatted. The final version may differ from this version. activator, its effectiveness is influenced by the presence of Gαs. In cells lacking Gαs, forskolin stimulated cAMP production was reduced (Darfler et al., 1982) . Our data suggest that AC6mut acts as a dominant negative mutant by interacting with Gαs to reduce the effects of Gαs on endogenous AC responsiveness to forskolin. Identification of AC6-interacting proteins and the consequences of such interactions in adult cardiac myocytes is a focus of study in our laboratories.
Inhibition of hypertrophy
PE, an α 1 -adrenergic receptor agonist, induces cardiac myocyte hypertrophy (Simpson, 1985) and cell death. Many genes are involved in PE-induced cardiac myocyte hypertrophy. For example, transcription of cardiac ankyrin repeat protein (CARP) is increased in PE-induced hypertrophy (Pinson et al., 1993) . In the present study, expression of AC6 or AC6mut reduced CARP expression and attenuated hypertrophy, through unknown mechanisms. Increased expression of AC6 in vivo was not associated with altered expression of βAR, Gαs or Giα2 , so the attenuation of hypertrophy observed following expression of AC6 or AC6mut in the present study, is not likely to be mediated through the ßAR-signaling pathway.
Moreover, AC6mut and AC6, which have opposite effects on cAMP production, have similar effects on the attenuation of hypertrophy.
Adult rat cardiac myocyte hypertrophy was confirmed by measuring protein synthesis using 3 H-leucine incorporation. As expected, when uninfected and Ad.Null-infected cardiac myocytes were treated with phenylephrine we saw increased apoptosis and necrosis. Protein synthesis was decreased by 20% when compared to cardiac myocytes not treated with phenylephrine. In essence, the confounding elements of increases in apoptosis and cell death make protein
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This article has not been copyedited and formatted. The final version may differ from this version. Fig. 3A and 3B ). These data suggest that PKA and CamKII are not involved in attenuation of PE-induced hypertrophy. Expression of AC6 or AC6mut did not alter the expression of hypertrophy-associated genes such as ANF and BNP, did not increase calcineurin A expression, and did not influence the ERK signaling pathway (data not shown), but inhibited CARP expression ( Fig. 3C and 3D ), which likely contributed to the attenuation of hypertrophy.
We recently reported that AC6 deletion reduced left ventricular hypertrophy in pressure- This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 4) . Although AC6mut expression did not increase isoproterenol-stimulated PLB phosphorylation at Thr17, its beneficial effects on Ca 2+ handling likely reflect reduced PLB expression, which was also seen after AC6 expression. Previous studies have established the tight linkage between levels of AC6 and calcium handling in the heart. For example cardiacdirected expression of AC6 was associated with increased SR Ca 2+ uptake . In contrast, hearts from AC6 deleted mice show substantially impaired Ca 2+ handling .
Conclusions
Expression of a catalytically inactive mutant of AC6 exhibited many of the beneficial biological effects seen with expression of the catalytically active normal AC6. Both AC6 and AC6mut reduced PLB expression, increased Ca 2+ handling, and reduced PE-induced cardiac
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B. Location of transgene proteins. Double immunofluorescence staining of AC6 and AC6mut
by anti-AU1 antibody (red), anti-caveolin 3 (Cav-3) antibody (green) and anti-protein disulphide-isomerase (PDI) antibody (green). Hoechst dye was used to identify the nucleus (blue). There were no apparent group differences in cellular distribution: AC6 and AC6mut
proteins were present in plasma membrane (associated with caveolin), nuclear envelope, and sarcoplasmic reticulum.
C. AC activity. Cyclic AMP was measured in uninfected (Con), Ad.AC6 and Ad.AC6mut infected cardiac myocytes before (basal) and after stimulation with isoproterenol (Iso, 10 μM, 10 min) or forskolin (Fsk, 10 μM, 10 min). As expected, AC6 increased cAMP generation in response to isoproterenol and forskolin stimulation. AC6mut was associated with reduced cAMP generation in response to isoproterenol (a 59% reduction) and forskolin (an 80% reduction). Bars in the graphs denote mean ± SD (***, p < 0.001) derived from triplicates in three independent experiments. This article has not been copyedited and formatted. The final version may differ from this version. 
D.
CARP protein expression. CARP protein was detected using anti-CARP antibody in immunoblotting and showed no group differences in the absence of PE. After PE treatment, AC6 and AC6mut expression reduced expression of CARP protein when compared with both uninfected and Ad.Null controls (**p<0.01).
E.
Calcineurin A protein expression. Calcineurin A protein was detected using anticalcineurin A antibody in immunoblotting. There were no differences among groups in the basal or PE-treated conditions.
F.
Calcineurin activity. Calcineurin activity was determined using the calcineurin cellular activity assay kit from Enzo Life Sciences. There were no differences among groups in the basal or PE-treated conditions.
In all graphs, bars represent mean values of 3 -4 experiments; error bars denote 1 SD. 
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B and C. Immunodetection of PLB phosphorylation at Ser16 and Thr17 using their specific
antibodies in cell homogenates of adult rat cardiac myocytes unstimulated or stimulated with isoproterenol (10 µM, 24 hr). AC6, but not AC6mut, increased basal PLB phosphorylation at the Ser16 site, but not the Thr17 site. After isoproterenol stimulation, PLB phosphorylation at Ser16 was increased similarly in all conditions, and phosphorylation at Thr17 was increased in all conditions, but was greater in AC6 than in AC6mut-infected cardiac myocytes.
D.
Immunodetection of troponin I phosphorylation at the Ser23/24 sites using anti-phospho-cTnI antibody in cell homogenates of adult rat cardiac myocytes, unstimulated or stimulated with isoproterenol (10 µM, 24 hr). AC6 and AC6mut did not ncrease basal cTnI phosphorylation, but isoproterenol treatment was associated with increased cTnI phosphorylation of similar
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Basal, P-Ser16-PLB ↑ 7-fold 0
Iso-stimulated, P-Thr17-PLB ↑ 2-fold 0
Iso-stimulated, P-23/24-TnI ↑ 1.6-fold ↑ 1.4-fold
The entries reflect summary of data from triplicate experiments in each case. "0" indicates no change; PE, phenylephrine; Fsk, forskolin; Iso, isoproterenol; PLB, phospholamban
